Hui‐Wen Lo

9.8k total citations · 4 hit papers
113 papers, 7.7k citations indexed

About

Hui‐Wen Lo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui‐Wen Lo has authored 113 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 53 papers in Molecular Biology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui‐Wen Lo's work include Brain Metastases and Treatment (26 papers), Glioma Diagnosis and Treatment (25 papers) and HER2/EGFR in Cancer Research (21 papers). Hui‐Wen Lo is often cited by papers focused on Brain Metastases and Treatment (26 papers), Glioma Diagnosis and Treatment (25 papers) and HER2/EGFR in Cancer Research (21 papers). Hui‐Wen Lo collaborates with scholars based in United States, China and Germany. Hui‐Wen Lo's co-authors include Mien‐Chie Hung, Richard L. Carpenter, Francis Ali‐Osman, Hu Zhu, Weiya Xia, Xinyu Cao, Michael D. Chan, Yongkun Wei, Richard Carpenter and Mohamed Ali‐Seyed and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Cell.

In The Last Decade

Hui‐Wen Lo

110 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression

2007 526 citations Hui‐Wen Lo, Weiya Xia et al. Cancer Research profile →
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors

2016 459 citations Tadas Rimkus, Shadi Qasem et al. profile →
STAT3 Target Genes Relevant to Human Cancers

2014 393 citations Richard L. Carpenter, Hui‐Wen Lo profile →
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

2022 173 citations Sara G. Manore, Daniel Doheny et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui‐Wen Lo United States	48	4.5k	3.3k	1.5k	1.5k	813	113	7.7k
Antonella De Luca Italy	38	3.6k 0.8×	3.4k 1.0×	1.4k 0.9×	1.7k 1.1×	279 0.3×	102	6.8k
Richard B. Lock Australia	53	5.1k 1.1×	2.8k 0.9×	1.2k 0.8×	952 0.6×	596 0.7×	260	8.7k
Ron Bose United States	33	3.5k 0.8×	3.1k 1.0×	1.2k 0.8×	1.3k 0.8×	285 0.4×	94	6.7k
Atanasio Pandiella Spain	57	6.6k 1.5×	4.9k 1.5×	1.5k 1.0×	1.2k 0.8×	667 0.8×	284	11.6k
Arnab Chakravarti United States	45	3.2k 0.7×	1.3k 0.4×	2.1k 1.4×	1.1k 0.7×	1.2k 1.4×	173	6.1k
Paul D. Smith United Kingdom	45	5.1k 1.1×	2.4k 0.7×	1.4k 0.9×	1.4k 1.0×	287 0.4×	120	7.5k
Dale L. Ludwig United States	36	4.4k 1.0×	1.6k 0.5×	993 0.7×	850 0.6×	430 0.5×	91	5.9k
Weiping Shu United States	16	4.4k 1.0×	3.8k 1.2×	2.2k 1.5×	1.2k 0.8×	270 0.3×	25	7.6k
Shom Goel United States	25	2.3k 0.5×	3.1k 0.9×	1.5k 1.0×	1.8k 1.2×	553 0.7×	71	5.8k
Pascal Finetti France	52	4.7k 1.0×	4.9k 1.5×	3.5k 2.3×	1.3k 0.9×	452 0.6×	175	9.8k

Countries citing papers authored by Hui‐Wen Lo

Since Specialization

Citations

This map shows the geographic impact of Hui‐Wen Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Wen Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Wen Lo more than expected).

Fields of papers citing papers by Hui‐Wen Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Wen Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Wen Lo. The network helps show where Hui‐Wen Lo may publish in the future.

Co-authorship network of co-authors of Hui‐Wen Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Wen Lo. A scholar is included among the top collaborators of Hui‐Wen Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Wen Lo. Hui‐Wen Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Liqian, Jacob Pfeil, Hui‐Wen Lo, et al.. (2025). Abstract A099: The IO-Atlas Project: A cross-cohort tumor immunophenotyping platform enhancing precision immuno-oncology. Cancer Immunology Research. 13(2_Supplement). A099–A099. 1 indexed citations

Regua, Angelina T., et al.. (2024). Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers. Cancer Letters. 597. 217023–217023. 9 indexed citations

Lo, Hui‐Wen, et al.. (2024). Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling. Current Oncology. 31(10). 5737–5751. 6 indexed citations

Wong, Grace Lai–Hung, et al.. (2023). Abstract 3769: Intracellular miR-1290 promotes breast cancer stemness in HER2-enriched and triple-negative breast cancer. Cancer Research. 83(7_Supplement). 3769–3769. 1 indexed citations

Sirkisoon, Sherona, Grace L. Wong, Daniel Doheny, et al.. (2022). Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases. Cancer Letters. 540. 215726–215726. 38 indexed citations

Regua, Angelina T., et al.. (2019). Trk receptor tyrosine kinases in metastasis and cancer therapy.. PubMed. 28(154). 195–203. 14 indexed citations

Xing, Fei, Yin Liu, Shih-Ying Wu, et al.. (2018). Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Research. 78(15). 4316–4330. 259 indexed citations

Rimkus, Tadas, Richard L. Carpenter, Sherona Sirkisoon, et al.. (2018). Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Research. 78(10). 2589–2600. 32 indexed citations

McTyre, E., M.C. LeCompte, Christina K. Cramer, et al.. (2017). The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: Results of a large single institution retrospective analysis. Clinical Neurology and Neurosurgery. 165. 24–28. 5 indexed citations

10.

Xing, Fei, Yin Liu, Sambad Sharma, et al.. (2016). Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer. Cancer Research. 76(17). 4970–4980. 102 indexed citations

11.

Lo, Hui‐Wen. (2015). EGFR and HER2 signaling in breast cancer brain metastasis. Frontiers in Bioscience-Elite. 8(2). 245–263. 57 indexed citations

12.

Carpenter, Richard L., Woody Han, Ivy Paw, & Hui‐Wen Lo. (2013). HER2 Phosphorylates and Destabilizes Pro-Apoptotic PUMA, Leading to Antagonized Apoptosis in Cancer Cells. PLoS ONE. 8(11). e78836–e78836. 15 indexed citations

13.

Lo, Hui‐Wen, Xinyu Cao, Hu Zhu, & Francis Ali‐Osman. (2010). Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes. Molecular Cancer Research. 8(2). 232–245. 157 indexed citations

14.

Lo, Hui‐Wen. (2010). EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance. Current Molecular Pharmacology. 3(1). 37–52. 113 indexed citations

15.

Lo, Hui‐Wen, Hu Zhu, Xinyu Cao, Amy J. Aldrich, & Francis Ali‐Osman. (2009). A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion. Cancer Research. 69(17). 6790–6798. 125 indexed citations

16.

Lo, Hui‐Wen, Mohamed Ali‐Seyed, Yadi Wu, et al.. (2006). Nuclear‐cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1. Journal of Cellular Biochemistry. 98(6). 1570–1583. 190 indexed citations

17.

Lo, Hui‐Wen & Mien‐Chie Hung. (2006). Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. British Journal of Cancer. 94(2). 184–188. 260 indexed citations

18.

Lo, Hui‐Wen, Chi‐Ping Day, & Mien‐Chie Hung. (2005). Cancer‐Specific Gene Therapy. Advances in genetics. 54. 233–255. 56 indexed citations

19.

Wang, Shao‐Chun, Huang‐Chun Lien, Weiya Xia, et al.. (2004). Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell. 6(3). 251–261. 241 indexed citations

20.

Lo, Hui‐Wen & Francis Ali‐Osman. (1998). Structure of the human allelic glutathione S-transferase-π gene variant, hGSTP1*C, cloned from a glioblastoma multiforme cell line. Chemico-Biological Interactions. 111-112. 91–102. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact